📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Epixis

1.1 - Company Overview

Epixis Logo

Epixis

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of advanced immuno-therapy development based on recombinant virus-like particles against hepatitis C, based in Paris, France.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Epixis

60 Degrees Pharmaceuticals Logo

60 Degrees Pharmaceuticals

HQ: United States Website
  • Description: Provider of medicines to treat and prevent infectious diseases, including ARAKODA (tafenoquine) for malaria prophylaxis in patients 18+, a Dengue Fever Treatment Program developing 60P001 (alpha-glucosidase inhibitor) and 60P002 (platelet-activating factor receptor antagonist), and a Malaria Prevention Program developing new drugs to address limitations of existing prophylactics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 60 Degrees Pharmaceuticals company profile →
Bluejay Diagnostics Logo

Bluejay Diagnostics

HQ: United States Website
  • Description: Provider of the Symphony automated diagnostic system using fluorescence immuno-analysis for rapid testing with integrated reagents in single-use cartridges; Symphony cartridges for blood processing and ELISA of specific biomarkers; and the Symphony IL-6 test for near-patient monitoring of disease progression.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bluejay Diagnostics company profile →
Abivax Logo

Abivax

HQ: France Website
  • Description: Provider of clinical-stage biotechnology therapies that mobilize the body's natural immune machinery to treat autoimmune diseases, viral infections, and cancer, including obefazimod for ulcerative colitis (Phase 3), planned Phase 2b for Crohn's disease, exploration as combination therapy for ulcerative colitis in preclinical studies, and nonclinical evaluation for additional chronic inflammatory indications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abivax company profile →
Achillion Pharmaceuticals Logo

Achillion Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies targeting the complement system, including Soliris for paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uraemic syndrome (aHUS) and neuromyelitis optica spectrum disorder; Ultomiris, a long-acting C5 complement inhibitor, for PNH, aHUS, generalised myasthenia gravis and NMOSD; and Strensiq for hypophosphatasia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Achillion Pharmaceuticals company profile →
Melinta Logo

Melinta

HQ: United States Website
  • Description: Provider of antibiotics, developing and commercializing antibiotics to overcome drug-resistant infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Melinta company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Epixis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Epixis

2.2 - Growth funds investing in similar companies to Epixis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Epixis

4.2 - Public trading comparable groups for Epixis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Epixis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Epixis

What does Epixis do?

Epixis is a provider of advanced immuno-therapy development based on recombinant virus-like particles against hepatitis C, based in Paris, France.

Who are Epixis's competitors?

Epixis's competitors and similar companies include 60 Degrees Pharmaceuticals, Bluejay Diagnostics, Abivax, Achillion Pharmaceuticals, and Melinta.

Where is Epixis headquartered?

Epixis is headquartered in France.

How many employees does Epixis have?

Epixis has 1,000 employees 🔒.

When was Epixis founded?

Epixis was founded in 2010 🔒.

What sector and industry vertical is Epixis in?

Epixis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Epixis

Who are the top strategic acquirers in Epixis's sector and industry

Top strategic M&A buyers and acquirers in Epixis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Epixis?

Top strategic M&A buyers groups and sectors for Epixis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Epixis's sector and industry vertical

Which are the top PE firms investing in Epixis's sector and industry vertical?

Top PE firms investing in Epixis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Epixis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Epixis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Epixis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Epixis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Epixis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Epixis?

The key public trading comparables and valuation benchmarks for Epixis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Epixis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Epixis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Epixis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Epixis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Epixis's' sector and industry vertical?

Access recent funding rounds and capital raises in Epixis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Epixis